Annual report [Section 13 and 15(d), not S-K Item 405]

Finance leases receivable (Details Narrative)

v3.25.1
Finance leases receivable (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jul. 11, 2023
Oct. 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Sep. 30, 2022
Aug. 31, 2022
Aug. 27, 2021
Apr. 24, 2019
Finance lease impairment           $ 783,880          
Selling, general and administrative expenses     $ 780,212 $ 1,775,210              
G Farma Settlors [Member]                      
Litigation settlement amount awarded from other party $ 2,539,597   2,539,597                
Litigation settlement default amount 2,494,450                    
Litigation settlement interest amount 40,219   $ 375,025                
Litigation settlement costs 1,643                    
Legal fees $ 3,285                    
Interest rate 10.00%                    
Settlement agreement and mutual release [Member] | G Farma Settlors [Member]                      
Liability for unpaid claims   $ 2,000,000           $ 2,000,000 $ 2,000,000 $ 2,000,000  
Remaining amount   494,450                  
Liability for unpaid claims and claims adjustment expense, net   500,000               $ 500,000  
Liability for accrued unpaid interest   $ 2,000,000                  
Bad debt expenses [Member]                      
Selling, general and administrative expenses         $ 19,519            
G Farma and Related Entities [Member]                      
Payment to acquire machinery and equipment             $ 996,000        
G FarmaLabs Limited [Member]                      
Cost of impounded assets                     $ 427,804
G Farmas [Member]                      
[custom:LeaseEquipmentAtCost-0]         622,569            
Proceeds from Sale of Lease Receivables         $ 249,481